Evidence map›Paper›PMID 37787853›Full record

ArticleAnalytical and bioanalytical chemistry2023

Variable fragmentation and ionization of amyloid-beta epimers and isomers.

Elizabeth R Readel, Umang Dhaubhadel, Arzoo Patel, Daniel W Armstrong

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elizabeth R ReadelDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, 76019, USA.
Umang DhaubhadelDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, 76019, USA.
Arzoo PatelDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, 76019, USA.
Daniel W ArmstrongDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, 76019, USA. sec4dwa@uta.edu.
The University of Texas at Arlington · US

Funding

Welch Foundation Y0026
6 · The paper itself

Abstract

While the existence of D-amino acids in peptides and proteins has recently been accepted in higher forms of life, their roles and importance are yet to be understood. The lack of analytical methods present for such epimeric and/or isomeric analyses often limits developments in the field. Studies have shown the elevated presence of epimeric and isomeric modifications to amyloid-beta (Aβ) peptides extracted from Alzheimer's disease patients. These modifications most frequently occur through aspartic acid and serine residues. Because such peptides are indistinguishable by mass alone, selective liquid chromatography tandem mass spectrometry analysis is required to differentiate such peptides. Herein, we examine MS/MS of tryptic fragments of Aβ peptides containing D-Asp, L-iso-Asp, D-iso-Asp, and/or D-Ser modifications. Peptide ionizability and fragmentation are explored through selected reaction monitoring, selected ion monitoring, and product ion scan. The results show the variability of ionization and fragmentation for many "identical mass peptides" and how these differences can affect the analysis of isomeric and epimeric peptides.

Indexed as

Alzheimer DiseaseTandem Mass SpectrometryAmyloid beta-PeptidesAspartic AcidHumansIsomerismPeptide FragmentsAmyloid beta-PeptidesAspartic AcidPeptide FragmentsAlzheimer’s diseaseAmyloid betaEpimersFragmentationIonizationMass spectrometry

Identifiers

PMID37787853
OpenAlexW4387296815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.